Long-acting depot antipsychotics were developed specifically to promote treatment
adherence (compliance) and they are a valuable option for patients requiring maintenance …

Background: Since 2002, a second-generation depot antipsychotic has been available that
potentially combines the advantages of depot administration and the favorable aspects of …

Background: Antipsychotic medications significantly ameliorate the symptoms of
schizophrenia, but patients are often noncompliant with these medications. Research …

In spite of their well known advantages, depot antipsychotics are seldom prescribed in the
treatment of schizophrenia. A frequently stated reason is the patient's objection to depot …

Depot neuroleptics, schizophrenia and the role of the nurse: is practice evidence based? A
review of the literature Nurses are expected to justify their practice with research based …

Antipsychotic depots are less frequently prescribed than oral compounds. In an
experimental study involving N= 106 psychiatrists we studied how much more effective with …

OBJECTIVE: The prescription rate of antipsychotic depots for patients suffering from
schizophrenia is currently low. Among these patients the assumable acceptance rate of …

BACKGROUND: A third of patients with schizophrenia are out of contact with secondary
services. Many of these patients receive maintenance medication as depot antipsychotics …

Some clinicians consider depot antipsychotics to be stigmatising, coercive and
unacceptable to patients. This cross-sectional study investigated patients' perspectives of …

Some clinicians believe that antipsychotic depot injections are unacceptable to patients.
This cross-sectional study investigated patients' attitudes regarding antipsychotics, and …